Implants News and Research

RSS

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial – Cardiac Resynchronization Therapy (MADIT-CRT) study demonstrated significant and sustained survival benefit for the indicated population.

31 Mar 2014

AccessClosure commercially launches Mynx Ace Vascular Closure Device

AccessClosure Inc., the market leader in extravascular care technology, has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system to seal femoral artery access sites.

29 Mar 2014

People urged to undergo oral cancer screenings as part of Oral Cancer Awareness Month

Oral and oropharyngeal cancer (cancer of the mouth and upper throat) collectively kill nearly one person every hour of every day of the year.

27 Mar 2014

Axonics Modulation Technologies completes $32.6 million Series A preferred stock financing

Axonics Modulation Technologies, Inc., a developer of novel implantable neuromodulation technology, announced today that it has completed a $32.6 million Series A preferred stock financing.

25 Mar 2014

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

ETG or Endogenous Tissue Growth is a new therapeutic category in which surgeons use implants designed to allow the body to repair itself by spontaneously growing natural, healthy tissue from the inside without the use of stem cells or animal-derived products.

25 Mar 2014

St. Jude Medical announces first enrollments in LEADLESS Pacemaker Observational Study

St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company’s LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.

19 Mar 2014

Surgeons perform first auditory brainstem implant operation in Northeast Ohio

Surgeons at University Hospitals Case Medical Center have completed the first auditory brainstem implant (ABI) operation in Northeast Ohio on a woman who has lost most of her hearing due to benign tumors on her auditory nerves.

17 Mar 2014

FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has approved the expansion of BIOTRONIK's ongoing ProMRI trial. The new phase of the trial (Phase C) will study the company's ProMRI technology in implantable cardioverter-defibrillator (ICD) devices.

14 Mar 2014

Surface topography and chemistry influence cellular behavior on semiconductors

Changing the texture and surface characteristics of a semiconductor material at the nanoscale can influence the way that neural cells grow on the material.

13 Mar 2014

Researchers receive $3 million grant from NIH to study effects of asymmetric hearing loss

Researchers at Washington University School of Medicine in St. Louis have received a five-year, $3 million grant from the National Institutes of Health (NIH) to study the effects of asymmetric hearing loss in adults and children.

13 Mar 2014

Beverly Hills Physicians receives ALLERGAN PARTNER PRIVILEGES Top 50 award

Throughout Southern California, Beverly Hills Physicians has long been the ideal option for cosmetic procedures like breast augmentation. With BHP's various facilities throughout the region (each approved by the American Association for Accreditation of Ambulatory Surgery, Inc.), their plastic surgery patients always know they're receiving the safest and most effective surgery.

13 Mar 2014

RTI Surgical launches 2 new biological solutions at AAOS annual meeting in New Orleans

RTI Surgical Inc., a leading global surgical implant company, is launching two new biological solutions at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans this week. NanOss Bioactive 3D, a synthetic three dimensional bioscaffold which supports bone formation, and map3™ Cellular Allogeneic Bone Graft, an implant that contains the three essential elements needed to generate and maintain new bone, will be introduced at the RTI Surgical exhibit at booth 5937 (Hall H) during the AAOS meeting.

12 Mar 2014

Study questions conventional wisdom that patients should wait 6 weeks after hip replacement before driving

After hip replacement surgery, many patients are anxious to resume driving, and a new study challenges the conventional wisdom that patients should wait six weeks before getting back behind the wheel.

12 Mar 2014

PowerVision develops world's first fluid-based accommodating intraocular lens

PowerVision, Inc., a medical device company developing the world's first fluid-based accommodating intraocular lens, today announced that the first 10 patients have received lens implants in its multi-center clinical study assessing the performance of the lens in cataract patients.

11 Mar 2014

Study: Rise of 'selfies' have huge impact on facial plastic surgery industry

The rise of 'selfies' is having a huge impact on the facial plastic surgery industry according to a new study by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The annual poll studies a select group of the organization's 2,700 members to uncover the latest trends in facial plastic surgery.

11 Mar 2014

UOC ventures into U.S. market to offer safe, cost-effective hip and knee devices

Today, United Orthopedic Corporation (UOC) - a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments - announced its entrance into the American market, offering clinically proven, safe and cost-effective hip and knee devices through its U.S. subsidiary, UOC USA.

7 Mar 2014

National clinical trial to test new avenue for tinnitus treatment

UT Southwestern Medical Center will take part in a national clinical trial to test a device that could provide relief for people suffering from tinnitus, a persistent buzzing or ringing sound in the ears. The device uses nervous system stimuli to rewire parts of the brain, in hopes of significantly reducing or removing tinnitus.

7 Mar 2014

Biodegradable scaffolds promote tissue growth during the healing process

Researchers from the University of Pittsburgh's Swanson School of Engineering and McGowan Institute for Regenerative Medicine (MIRM) are proposing that if 3-D printers, or additive manufacturing, can produce custom replacement parts for machines, why couldn't the same process create biodegradable tissue repair structures for the human body?

7 Mar 2014

Treating long wait-times dictate long-term success of spinal cord stimulation therapy

Success rates soared to 75% for patients who waited less than 2 years for a spinal cord stimulator (SCS) implant, compared with 15% for patients whose implants happened 20 years after the onset of pain, according to a retrospective analysis.

7 Mar 2014

Cataract surgery followed by use of contact lenses may be better solution for infants

For adults and children who undergo cataract surgery, implantation of an artificial lens is the standard of care. But a clinical trial suggests that for most infants, surgery followed by the use of contact lenses for several years—and an eventual lens implant—may be the better solution.

7 Mar 2014

Implants News and Research

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

AccessClosure commercially launches Mynx Ace Vascular Closure Device

People urged to undergo oral cancer screenings as part of Oral Cancer Awareness Month

Axonics Modulation Technologies completes $32.6 million Series A preferred stock financing

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

St. Jude Medical announces first enrollments in LEADLESS Pacemaker Observational Study

Surgeons perform first auditory brainstem implant operation in Northeast Ohio

FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

Surface topography and chemistry influence cellular behavior on semiconductors

Researchers receive $3 million grant from NIH to study effects of asymmetric hearing loss

Beverly Hills Physicians receives ALLERGAN PARTNER PRIVILEGES Top 50 award

RTI Surgical launches 2 new biological solutions at AAOS annual meeting in New Orleans

Study questions conventional wisdom that patients should wait 6 weeks after hip replacement before driving

PowerVision develops world's first fluid-based accommodating intraocular lens

Study: Rise of 'selfies' have huge impact on facial plastic surgery industry

UOC ventures into U.S. market to offer safe, cost-effective hip and knee devices

National clinical trial to test new avenue for tinnitus treatment

Biodegradable scaffolds promote tissue growth during the healing process

Treating long wait-times dictate long-term success of spinal cord stimulation therapy

Cataract surgery followed by use of contact lenses may be better solution for infants

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News